Lasmiditan hydrochloride
CAS No. 613677-28-4
Lasmiditan hydrochloride ( LY 573144 hydrochloride ;COL-144 hydrochloride )
Catalog No. M21603 CAS No. 613677-28-4
Lasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 70 | Get Quote |
|
5MG | 99 | Get Quote |
|
10MG | 148 | Get Quote |
|
25MG | 267 | Get Quote |
|
50MG | 400 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLasmiditan hydrochloride
-
NoteResearch use only not for human use.
-
Brief DescriptionLasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM).
-
DescriptionLasmiditan hydrochloride is a novel centrally acting highly selective 5-HT(1F) receptor agonist (K1:2.21 μM)?.
-
SynonymsLY 573144 hydrochloride ;COL-144 hydrochloride
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research AreaNeurological Disease
-
IndicationAcute Migraine
Chemical Information
-
CAS Number613677-28-4
-
Formula Weight413.82
-
Molecular FormulaC19H19ClF3N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:28 mg/mL (67.66 mM)
-
SMILESCl.CN1CCC(CC1)C(=O)c1cccc(NC(=O)c2c(F)cc(F)cc2F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matilde Capi Fernando de Andrés Luana Lionetto. Lasmiditan for the Treatment of Migraine.Expert Opin Investig Drugs. 2017 Feb;26(2):227-234.
molnova catalog
related products
-
Aniracetam
Aniracetam(Ro 13-5057) is a nootropics and neuroprotective drug, which is selectively modulates the AMPA receptor and nAChR.
-
Nelotanserin
A potent, selective 5-HT2A inverse agonist with pKi of 9.2; displays >30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.
-
PF-05212377
PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.